Machine signal
Active cluster sell — 6 distinct insiders, $4.6M, window ends Sep 11, 2026.
Figures computed from official regulatory filings — .
Analysttarget 100.96 USD (+19%) · consensus 4.38/5 · 22 buy · 7 hold · 0 sell
Ownershipinsiders 0.19% · institutions 95.61% · short 1.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Edwards Lifesciences Corp only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
12 buys2,881 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Markowitz Wayne | Other | $30.8K | SEC |
| Markowitz Wayne | Other | $47.9K | SEC |
| Dahl Andrew M. | Other | $21.3K | SEC |
| Lippis Daniel J. | Exercise | $45K | SEC |
| Lippis Daniel J. | Sell | $54.2K | SEC |
| Chopra Daveen | Other | $34.5K | SEC |
| Lippis Daniel J. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dahl Andrew M. | Sell | $49.5K | SEC |
| Bruls Annette | Sell | $237.9K | SEC |
| Markowitz Wayne | Sell | $113.4K | SEC |
| Chopra Daveen | Sell | $2.8M | Unusual size | SEC |
| Chopra Daveen | Exercise | $2.3M | Unusual size | SEC |
| Chopra Daveen | Sell | $105.9K | SEC |
| Chopra Daveen | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lippis Daniel J. | Sell | $57K | SEC |
| Lippis Daniel J. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lippis Daniel J. | Exercise | $45K | SEC |
| Markowitz Wayne | Sell | $12.6K | SEC |
| Markowitz Wayne | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Markowitz Wayne | Exercise | $712.7K | SEC |
| Markowitz Wayne | Sell | $819K | Unusual size | SEC |
| Zovighian Bernard J | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Zovighian Bernard J | Sell | $245.1K | SEC |
| Zovighian Bernard J | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bruls Annette | Other | $10.1K | SEC |